ATH 14.3% 0.3¢ alterity therapeutics limited

Neurodegenerative diseases such as AD, PD, MSA, etc. are the...

  1. 2,812 Posts.
    lightbulb Created with Sketch. 981
    Neurodegenerative diseases such as AD, PD, MSA, etc. are the main focus of ATH. How they relate to other types of diseases is interesting, IMO. Strangely, AD patients and PD patients' risk of getting type 2 diabetes is elevated but there are differences. The list of "lower odds" is interesting in the paper above. I do not think it is similar to the corresponding list in PD. So this paper is general info about neurodegenerative diseases.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(14.3%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $381 109K

Buyers (Bids)

No. Vol. Price($)
42 60011843 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 125715587 24
View Market Depth
Last trade - 14.28pm 23/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.